Michael Gray
Chief Financial Officer and Chief Business Officer
Arsanis
Austria
Biography
Michael Gray, MBA, CPA, has nearly 20 years of industry business development and financial leadership experience, including financial strategy, planning, and operations. Prior to Arsanis, Mr. Gray spent 15 years in leadership positions at Curis, Inc., a publicly-held oncology drug development company, including Chief Financial Officer, Chief Business Officer, and Chief Operating Officer. He was instrumental in financial and business development transactions that raised over $350 million for the company, including partnering, equity, and debt transactions. Previously, Mr. Gray held positions including Controller and de facto Chief Financial Officer of Reprogenesis, a biotechnology company focused on the development of cell therapy drug candidates. Mr. Gray has also served as an audit professional for the accounting and consulting firm of Ernst & Young, LLP. Mr. Gray holds an active Certified Public Accountant license (Rhode Island). He earned his MBA in corporate finance and entrepreneurial management from the F.W. Olin Graduate School of Business at Babson College and a Bachelor of Science in Accounting from Bryant College.
Research Interest
Managemet
